BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36333683)

  • 1. Whether surgical resection or biopsy makes difference in single lesion primary central nervous system lymphoma: a single center retrospective cohort study.
    Cheng X; Chen H; Sun C; Zhang B; Zhang J; Wang Y
    BMC Neurol; 2022 Nov; 22(1):411. PubMed ID: 36333683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients.
    Wu S; Wang J; Liu W; Hu F; Zhao K; Jiang W; Lei T; Shu K
    BMC Neurol; 2021 May; 21(1):190. PubMed ID: 33975554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma.
    Ouyang T; Wang L; Zhang N; Zhang Z; Xiong Y; Li M; Hong T
    World Neurosurg; 2020 Jul; 139():e508-e516. PubMed ID: 32311566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of comorbidity indices and histochemical markers in surgically resected and non-resected primary central nervous system lymphoma.
    Wong CE; Liao WA; Chang Y; Lee PH; Huang CC; Chang KC; Lee JS
    Clin Exp Med; 2023 Nov; 23(7):3799-3807. PubMed ID: 37491648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis.
    Chojak R; Koźba-Gosztyła M; Polańska K; Rojek M; Chojko A; Bogacz R; Skorupa N; Więcław J; Czapiga B
    J Neurooncol; 2022 Dec; 160(3):753-761. PubMed ID: 36449256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
    Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
    [No Abstract]   [Full Text] [Related]  

  • 7. The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis.
    Cloney MB; Sonabend AM; Yun J; Yang J; Iwamoto F; Singh S; Bhagat G; Canoll P; Zanazzi G; Bruce JN; Sisti M; Sheth S; Connolly ES; McKhann G
    J Neurooncol; 2017 Mar; 132(1):189-197. PubMed ID: 28116650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive Surgery for Primary Central Nervous System Lymphoma: Is it time to consider extent of resection?
    Singhal S; Antoniou E; Kwan E; Gregory G; Lai LT
    J Clin Neurosci; 2022 Dec; 106():110-116. PubMed ID: 36274297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of primary central nervous system lymphoma: impact of patient selection on overall survival.
    Schellekes N; Barbotti A; Abramov Y; Sitt R; Di Meco F; Ram Z; Grossman R
    J Neurosurg; 2021 Feb; 135(4):1016-1025. PubMed ID: 33636699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Craniotomy and Survival for Primary Central Nervous System Lymphoma.
    Rae AI; Mehta A; Cloney M; Kinslow CJ; Wang TJC; Bhagat G; Canoll PD; Zanazzi GJ; Sisti MB; Sheth SA; Connolly ES; McKhann GM; Bruce JN; Iwamoto FM; Sonabend AM
    Neurosurgery; 2019 Apr; 84(4):935-944. PubMed ID: 29660011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Resection for Primary Central Nervous System Lymphoma: A Systematic Review.
    Labak CM; Holdhoff M; Bettegowda C; Gallia GL; Lim M; Weingart JD; Mukherjee D
    World Neurosurg; 2019 Jun; 126():e1436-e1448. PubMed ID: 30904794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resection versus biopsy for management of primary central nervous system lymphoma: a meta-analysis.
    Stifano V; Della Pepa GM; Offi M; Montano N; Carcagnì A; Pallini R; Lauretti L; Olivi A; D'Alessandris QG
    Neurosurg Rev; 2023 Jan; 46(1):37. PubMed ID: 36645525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patients.
    Zuo J; Lei T; Zhong S; Zhou J; Liu R; Wu C; Li S
    Neurosurg Rev; 2023 Dec; 47(1):17. PubMed ID: 38112846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Rituximab in Treatment of Patients With Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Meta-Analysis.
    Zhang Y; Liu Z; Gao C; Bian H; Ma Y; Jing F; Zhao X
    Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):733-741. PubMed ID: 37453867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
    Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
    Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection or Biopsy: The Efficacy of Different Surgical Approaches for Primary Central Nervous System Lymphoma.
    Zhang Y; Wang Z; Wang D; Yu B; Wen J; He S; Zeng W; Wang C
    Turk Neurosurg; 2024; 34(3):401-406. PubMed ID: 38650554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Primary Central Nervous System Lymphoma Treated with Combined Surgical Resection and High- Dose Methotrexate Chemotherapy: A Single-Institution Retrospective Study.
    Zhang Q; Wang DW; Shu HS
    Turk Neurosurg; 2022; 32(1):1-5. PubMed ID: 35018626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?
    de Pádua Covas Lage LA; Araújo Soares V; Meneguin TD; Culler HF; Reichert CO; Jacomassi MD; Reis DGC; Zerbini MCN; de Oliveira Costa R; Rocha V; Pereira J
    Radiat Oncol; 2022 Oct; 17(1):171. PubMed ID: 36273167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Outcome and Overall Survival in Patients with Primary or Secondary CNS Lymphoma after Surgical Resection vs. Biopsy.
    Staub-Bartelt F; Rittenauer J; Sabel M; Rapp M
    Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery plus adjuvant radiotherapy for primary central nervous system lymphoma.
    Kinslow CJ; Rae AI; Neugut AI; Adams CM; Cheng SK; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Iwamoto FM; Sonabend AM; Wang TJC
    Br J Neurosurg; 2020 Dec; 34(6):690-696. PubMed ID: 31931632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.